European Archives of Oto-Rhino-Laryngology,
Journal Year:
2021,
Volume and Issue:
278(10), P. 4091 - 4099
Published: April 15, 2021
SARS-CoV-2
vaccines
are
a
key
step
in
fighting
the
pandemic.
Nevertheless,
their
rapid
development
did
not
allow
for
testing
among
specific
population
subgroups
such
as
pregnant
and
breastfeeding
women,
or
elaborating
guidelines
healthcare
personnel
working
high
infection
risk
specialties,
otolaryngology
(ORL).
This
clinical
consensus
statement
(CCS)
aims
to
offer
guidance
vaccination
this
high-risk
based
on
best
evidence
available.
A
multidisciplinary
international
panel
of
33
specialists
judged
statements
through
two-round
modified
Delphi
method
survey.
Statements
were
designed
encompass
following
topics:
SARS-Cov-2
use
protective
equipment
ORL;
respective
risks
mother/child
dyad;
counseling
pregnant,
breastfeeding,
fertile
workers
(PBFHW).
All
ORL
PBFHW
considered
target
audience.
Of
13
statements,
7
reached
strong
consensus,
2
no
near-consensus.
According
with
otorhinolaryngologists-head
neck
surgeons
who
childbearing
potential
should
have
opportunity
receive
vaccination.
Moreover,
personal
(PPE)
still
be
used
even
after
Until
prospective
evaluations
these
topics
available,
ORL-HNS
must
specialty.
While
PPE
remains
pivotal,
allowed
access
provided
they
up-to-date
information.
The Pediatric Infectious Disease Journal,
Journal Year:
2025,
Volume and Issue:
44(2S), P. S111 - S113
Published: Feb. 1, 2025
The
coronavirus
disease
2019
pandemic
encouraged
rapid
vaccine
development,
with
a
fast-evolving
evidence
base
pre-
and
post-implementation.
We
developed
comprehensive
web
hub
to
promote
swift
information
synthesis
for
present
future
threats.
By
expanding
our
periodically
updated
living
systematic
review
Chikungunya,
Lassa
fever,
Disease
X,
we
will
continuously
capture
data
on
safety
effectiveness.
PLoS ONE,
Journal Year:
2021,
Volume and Issue:
16(9), P. e0256080 - e0256080
Published: Sept. 13, 2021
Prenatal
care
providers
will
play
an
important
role
in
the
acceptance
of
SARS-Cov-2
vaccination
for
pregnant
women.To
determine
perceptions
French
prenatal
providers:
midwives,
general
practitioners
(GPs)
and
obstetricians
gynaecologists
(Ob-Gyn)
regarding
SARS-CoV-2
during
pregnancy.An
anonymous
online
survey
was
sent
to
members
professional
societies
representing
practitioners.
The
participants
were
asked
answer
questions
on
their
characteristics
give
opinions
vaccine
themselves
women
who
are
or
willing
become
pregnant.Access
opened
from
January
11th,
2021,
March
1st,
2021.
A
total
1,416
responses
collected
749
Ob-Gyn,
598
midwives
69
GPs.
Most
respondents
(86.7%
overall,
90.4%
Ob-GYN,
81.1%
GPs
80.1%
midwives)
agreed
receive
vaccine.
Vaccination
against
would
be
offered
by
49.4%
95%CI
[48.1-50.8]
participants.
Midwives
less
likely
recommend
than
GP
Ob-Gyn
(37.5%,
50.7%
58.8%,
respectively).
multinomial
logistic
regression
revealed
that
being
obstetrician,
working
a
group,
usually
offering
flu
wanting
vaccinated
positively
associated
with
considering
vaccination.Most
healthcare
favourable
towards
vaccinating
women,
but
large
minority
express
reservation.
More
evidence
safety
involvement
organisations
encourage
access
SARS-CoV-2.
Vaccines,
Journal Year:
2021,
Volume and Issue:
9(11), P. 1351 - 1351
Published: Nov. 18, 2021
Vaccines
have
been
developed
under
accelerated
timelines
to
combat
the
COVID-19
pandemic
caused
by
SARS-CoV-2
coronavirus.
Although
they
are
considered
best
approach
for
preventing
mortality,
when
assessing
safety
of
these
vaccines,
pregnant
women
not
included
in
clinical
trials.
Thus,
vaccine
this
demographic,
as
well
developing
fetus
and
neonate,
remains
be
determined.
A
global
effort
has
underway
encourage
get
vaccinated
despite
uncertain
risk
posed
them
their
offspring.
Given
this,
post-hoc
data
collection,
potentially
years,
will
required
determine
outcomes
vaccination
on
next
generation.
Most
reactions
include
injection
site
erythema,
pain,
swelling,
fatigue,
headache,
fever
lymphadenopathy,
which
may
sufficient
affect
fetal/neonatal
development.
In
review,
we
explored
components
first-generation
viral
vector
mRNA
vaccines
that
believed
contribute
adverse
negatively
impact
fetal
neonatal
We
followed
with
a
discussion
potential
using
an
ovine
model
explore
long-term
during
prenatal
periods.
Medical Review,
Journal Year:
2022,
Volume and Issue:
2(1), P. 23 - 49
Published: Feb. 1, 2022
Abstract
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
has
caused
hundreds
of
millions
infections
and
deaths
over
past
two
years.
Currently,
many
countries
have
still
not
been
able
to
take
the
pandemic
under
control.
In
this
review,
we
systematically
summarized
what
done
mitigate
COVID-19
pandemic,
from
perspectives
virus
transmission,
public
health
control
measures,
development
vaccination
vaccines.
As
a
most
likely
coming
bats,
SARS-CoV-2
may
transmit
among
people
via
airborne,
faecal-oral,
vertical
or
foodborne
routes.
Our
meta-analysis
suggested
that
R
0
was
2.9
(95%
CI:
2.7–3.1),
estimates
in
Africa
Europe
could
be
higher.
The
median
t
decrease
by
23–96%
following
nonpharmacological
interventions,
including
lockdown,
isolation,
social
distance,
face
mask,
etc.
Comprehensive
intervention
lockdown
were
effective
measures
pandemic.
According
pooled
our
meta-analysis,
there
should
at
least
93.3%
89.9–96.2%)
being
vaccinated
around
world.
Limited
amount
vaccines
inequity
issues
vaccine
allocation
call
for
more
international
cooperation
achieve
anti-epidemic
goals
fairness.
Vaccines,
Journal Year:
2021,
Volume and Issue:
9(8), P. 907 - 907
Published: Aug. 15, 2021
This
case
reports
on
the
successful
maternal
to
fetal
transfer
of
neutralizing
antibodies
after
vaccination
with
BNT162b2
in
a
pregnant
woman
at
25
weeks
gestation.
The
levels
were
approximately
5-fold
higher
umbilical
cord
than
blood
while
level
total
showed
only
2-fold
increase.
suggest
that
crossed
syncytiotrophoblast
cell
barrier
have
specific
characteristics
correlate
functional
capacity.
Although
and
lactating
women
been
excluded
from
clinical
trials
for
several
reasons
including
ethical
concerns
about
exposure,
accumulating
evidence
has
now
revealed
these
vaccines
are
safe
efficient
both
fetus
woman.
Vaccination
against
COVID-19
pregnancy
is
vital
control
disease
burden
decrease
morbidity
ante-,
peri-
post-natal
periods.
Inclusion
research
programs
development
SARS-CoV-2
should
be
mandatory
provide
this
population
equitable
benefits
vaccine
research.
Health Psychology,
Journal Year:
2022,
Volume and Issue:
42(8), P. 567 - 576
Published: Sept. 8, 2022
Pregnant
women
are
a
vulnerable
population
for
coronavirus
disease
2019
(COVID-19)
due
to
their
risk
severe
symptoms
and
adverse
perinatal
outcomes.
Our
objective
was
identify
contributors
COVID-19
vaccine
intention
in
pregnancy
subsequent
uptake,
informed
by
the
Theory
of
Planned
Behavior,
Health
Belief
Model,
paradigms
implicating
social
determinants
health
(SDoH).
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2021,
Volume and Issue:
unknown
Published: Dec. 13, 2021
Studies
are
needed
to
evaluate
the
safety
and
effectiveness
of
mRNA
SARS-CoV-2
vaccination
during
pregnancy,
levels
protection
provided
their
newborns
through
placental
transfer
antibodies.
We
evaluated
transplacental
vaccine
products
functional
anti-SARS-CoV-2
antibodies
pregnancy
early
infancy
in
a
cohort
20
individuals
vaccinated
pregnancy.
found
no
evidence
maternal
blood,
placenta
tissue,
or
cord
blood
at
delivery.
However,
we
time-dependent
efficient
IgG
neutralizing
neonate
that
persisted
infancy.
Additionally,
using
phage
immunoprecipitation
sequencing,
vaccine-specific
signature
Spike
protein
epitope
binding
is
transplacentally
transferred
In
conclusion,
vaccines
not
fetus
however
timing
critical
ensure
protective
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2021,
Volume and Issue:
unknown
Published: Dec. 18, 2021
Abstract
Introduction
This
study
aims
to
characterize
attitudes
towards
COVID-19
vaccination
and
evaluate
factors
associated
with
vaccine
uptake
amongst
pregnant
individuals.
Methods
An
anonymous
survey
was
distributed
a
convenience
sample
of
individuals
receiving
prenatal
care
at
two
large
urban
academic
hospitals
in
single
healthcare
network
Massachusetts.
Individual
demographic
variables
were
included
the
along
questions
assessing
pregnancy.
Results
Of
477
respondents,
233
(49.3%)
had
received
or
scheduled
receive
vaccine.
Age,
White
race,
non-Hispanic/LatinX
ethnicity,
working
from
home,
typical
receipt
influenza
vaccination.
276
respondents
(58.4%)
reported
that
their
provider
recommended
pregnancy;
these
participants
more
likely
have
(OR
5.82,
95%
confidence
interval
[CI]
3.68-9.26).
Vaccinated
less
be
worried
about
effects
on
themselves
0.18,
CI
0.12-0.27)
developing
babies
0.17,
0.11-0.26).
Unvaccinated
report
it
is
easy
schedule
0.56,
0.34-0.93),
travel
0.19,
0.10-0.36),
miss
work
0.30,
0.18-0.48).
Conclusions
Strategies
are
needed
improve
patient
education
regarding
side
safety
pregnancy
change
policy
make
feasible
for
patients
without
loss
pay
get
vaccinated.
Key
Points
There
racial
ethnic
disparities
concerned
growing
babies.
cited
scheduling-related
barriers
vaccination,
indicating
areas
advocacy